Company Filing History:
Years Active: 2003-2008
Title: **Robert A De Man: An Innovator in Viral Variant Detection**
Introduction
Robert A De Man is a notable inventor based in Rotterdam, Netherlands. With a strong focus on viral research, he holds two patents that contribute significantly to the understanding and detection of viral variants, particularly in relation to hepatitis B. His work not only showcases his innovative spirit but also addresses critical needs in the health sector.
Latest Patents
De Man's latest patents revolve around the detection of viral variants. Specifically, one key patent is titled "Viral variants and methods for detecting same." This invention pertains to viral variants that demonstrate reduced sensitivity to specific agents and mechanisms that interact with immunological reagents. More importantly, it focuses on hepatitis B variants that exhibit complete or partial resistance to nucleoside analogues and reduced interactions with antibodies designed for viral surface components. Additionally, these patents contemplate assays that are valuable for monitoring antiviral therapeutic regimes, providing vital tools for healthcare professionals in managing hepatitis B infections.
Career Highlights
Throughout his career, Robert A De Man has made significant contributions to the healthcare landscape. He has worked with reputable organizations such as the Western Health Care Network and Melbourne Health. His roles at these institutions have allowed him to collaborate with leading professionals in the field of viral research.
Collaborations
De Man has collaborated with notable figures in his research endeavors, including Stephen Alister Locarnini and Angeline Ingrid Bartholomeusz. These collaborations have played a pivotal role in advancing the understanding of viral variants and their implications in medical treatments.
Conclusion
Robert A De Man's contributions to the field of viral research through his innovative patents and career collaborations highlight the importance of continued advancements in medical science. His work not only enriches the scientific community but also aims to improve therapeutic strategies for managing viral infections, showcasing the enduring impact of his innovations.